Telomir Pharmaceuticals (TELO) Change in Accured Expenses (2023 - 2025)
Telomir Pharmaceuticals (TELO) reported Change in Accured Expenses of $675,631 for Q4 2025, up 733.5% from $81,055 a year earlier and up 807.9% from the prior quarter.
Powered by 
Analysis
Telomir Pharmaceuticals (TELO) Change in Accured Expenses (2023 - 2025) Analysis & Trends
For FY2025, Telomir Pharmaceuticals posted Change in Accured Expenses of $417,470, up 127.3% from FY2024.
- Change in Accured Expenses has a three-year compound annual growth rate of 2.7% (FY2022 to FY2025).
- By year, Change in Accured Expenses came in at $183,629 in FY2024 (+60.3%), $114,556 in FY2023 (-70.3%) and $385,486 in FY2022.
- The Q4 2025 figure ranks as the highest quarterly Change in Accured Expenses since Q2 2023.
- Per Business Quant data, the three quarters before Q4 2025 came in at $74,419 (Q3 2025), -$303,905 (Q2 2025) and -$28,675 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accured Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 2.96 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 1.20 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -251.00 Mn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | - |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 901.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 338.00 Mn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Telomir Pharmaceuticals | 81.15 Mn | 81.15 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 675,631.00 |
| Sep 30, 2025 | 74,419.00 |
| Jun 30, 2025 | -303,905.00 |
| Mar 31, 2025 | -28,675.00 |
| Dec 31, 2024 | 81,055.00 |
| Sep 30, 2024 | 112,665.00 |
| Jun 30, 2024 | -84,835.00 |
| Mar 31, 2024 | 74,744.00 |
| Dec 31, 2023 | 22,750.00 |
| Sep 30, 2023 | -1.05 Mn |
| Jun 30, 2023 | 1.39 Mn |
| Mar 31, 2023 | -252,801.00 |
API Access
Telomir Pharmaceuticals Change in Accured Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=TELO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-accured-expenses", "ticker": "TELO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=TELO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();